DefinePK

Abstract

The COVID-19 pandemic has significantly disrupted global healthcare systems, with cancer care being notably affected. Millions of cancer patients worldwide have faced delayed diagnoses, treatment interruptions, and worsened outcomes due to the healthcare system's overburdening during the pandemic. The overlap between COVID-19 symptoms and cancer markers has created challenges in diagnosing and managing both conditions simultaneously. Cancer patients, particularly those undergoing active treatment, are at heightened risk for severe COVID-19 symptoms, further complicating their care. Additionally, the pandemic has exacerbated existing healthcare disparities, especially in rural and underserved areas, where access to cancer care is already limited. Financial burdens, psychological distress, and increased fear of recurrence further impact cancer patients' quality of life. The growing reliance on telemedicine has provided a temporary solution for continuity in care, though it presents challenges related to accessibility, patient satisfaction, and provider preferences. To prepare for future health emergencies, strengthening global collaboration, improving telemedicine infrastructure, and increasing cancer screening and prevention efforts are essential. This review highlights the profound impact of COVID-19 on cancer care and offers recommendations to mitigate these challenges in future crises.